NRX
NRX Pharmaceuticals underwrites 5.7M share offering at $8.75 per share
NRX Pharmaceuticals entered into an underwriting agreement with BTIG LLC to sell 5.7 million common shares with a 857,142 share overallotment option. The offering is registered under a Form S-3 shelf registration statement and represents a capital raise for the biopharmaceutical company.
NRX
NexPoint Diversified Real Estate Trust adopts 2026 Long Term Incentive Plan
NexPoint Diversified Real Estate Trust filed its 2026 Long Term Incentive Plan to attract and retain trustees, officers, and key employees through equity and cash-based incentives. The plan establishes a framework for awarding restricted shares, appreciation rights, and cash incentives tied to perfo…
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.